Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolism

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Spiros Miyakis, Michael D. Lockshin, Tatsuya Atsumi et al. · Journal of Thrombosis and Haemostasis · 2006 · 7.1K citations · Full text

Medicine, Hematology, Internal Medicine +10

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

New England Journal of Medicine · 2010 · 3.2K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

New England Journal of Medicine · 2012 · 2.3K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH

Scott Kaatz, Alex C. Spyropoulos, Sam Schulman · Journal of Thrombosis and Haemostasis · 2015 · 1.4K citations

Medicine, Cardiology, Clinical Sciences +16

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

Martin H. Prins, Anthonie WA Lensing, Rupert Bauersachs et al. · Thrombosis Journal · 2013 · 553 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17